Aon Canada is forming an alliance with the Reformulary Group that pairs its health and benefits consulting experience with the Toronto-based formulary management company’s specialist drug expertise.
Through the partnership, the Reformulary Group will be Aon’s partner in formulary design, and both organizations will integrate their analytics to create better health and financial outcomes, according to a release.
“We hope to use our combined expertise to bring solutions to Aon’s clients and help them to achieve better health and financial outcomes,” said Helen Stevenson, founder and chief executive officer of the Reformulary Group.
Read: The debate over drug formularies
Anthony Perlman, senior vice-president and national practice leader at Aon, noted the partnership will allow both companies to help employers navigate the evolving drug environment. “Clients spend a significant amount of money, from both an employer and employee perspective, and this partnership is another example of our continued focus on driving value for our clients. The output from this partnership will better assist plan sponsors in managing this aspect of the benefits programs.”
The release also noted the partnership won’t be exclusive, allowing both companies to collaborate with other companies and partners.